2024
The development of lateral flow devices for urinary biomarkers to assess kidney health
D Souza S, Obeid W, Hernandez J, Hu D, Wen Y, Moledina D, Albert A, Gregg A, Wheeler A, Philbrook H, Parikh C. The development of lateral flow devices for urinary biomarkers to assess kidney health. Scientific Reports 2024, 14: 8516. PMID: 38609491, PMCID: PMC11014899, DOI: 10.1038/s41598-024-59104-5.Peer-Reviewed Original ResearchConceptsLateral flow deviceInterleukin-9Development of lateral flow devicesUrinary biomarkersDetection antibody concentrationSerum creatinine levelsKidney healthPaired antibodiesEnzyme Linked Immunosorbent AssayCreatinine levelsKidney injuryKidney functionOsteopontinImmunosorbent assayAntibody concentrationsMeasured biomarkersKidneyReal-time changesBiomarkers
2023
Associations of Baseline and Longitudinal Serum Uromodulin With Kidney Failure and Mortality: Results From the African American Study of Kidney Disease and Hypertension (AASK) Trial
Chen T, Estrella M, Appel L, Surapaneni A, Köttgen A, Obeid W, Parikh C, Grams M. Associations of Baseline and Longitudinal Serum Uromodulin With Kidney Failure and Mortality: Results From the African American Study of Kidney Disease and Hypertension (AASK) Trial. American Journal Of Kidney Diseases 2023, 83: 71-78. PMID: 37690632, DOI: 10.1053/j.ajkd.2023.05.017.Peer-Reviewed Original ResearchConceptsRisk of kidney failureChronic kidney diseaseAssociated with mortalityKidney diseaseKidney failureRisk of KFRTSerum uromodulinCohort of African American adultsReplacement therapyUromodulin levelsHigh riskUrine protein-creatinine ratioAfrican American adultsStored serum samplesGlomerular filtration rateBlood pressure goalsProtein-creatinine ratioAbstractText Label="RESULTS">Levels of uromodulinStudy of Kidney DiseaseAfrican American Study of Kidney DiseaseRandomized treatment groupsAssociation of baselineBaseline demographic factorsCox proportional hazards